Ticker Symbol: RARE
Ultragenyx Pharmaceutical Inc.
$79.09 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001515673
Company Profile
Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 60 Leveroni Ct
Website: www.ultragenyx.com
CEO: Emil Kakkis
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $33.57
Change:
$0.93
(
2.85%)
Days Range: $32.01 - $33.61
Beta: 1.17
52wk. High: $54.98
52wk. Low: $31.62
Ytd. Change -24.69%
50 Day Moving Average: $36.60
200 Day Moving Average: $42.12
Shares Outstanding: 71488598
Valuation
Market Cap: 240.0B
PE Ratio: -3.28
EPS (TTM): -10.24
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A